Position papers
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Str......
AIM reacts to the publication of the European Pharmaceutical Strategy roadmap
A fair diagnosis but will the treatment match ? The European Commission has published the roadmap to the European Pharmaceutical Strategy. AIM, the leading international umbrella organisation of healt......
EU Collaboration on Vaccination
The current outbreak of COVID-19, its crippling effects on European economies and societies and the race to find a vaccine against the disease have put to the fore the fragility of our societies. It h......
Artificial intelligence in healthcare: a great potential in an ecosystem of trust!
The international umbrella organization of mutual benefit societies (AIM) welcomes the priority focus of the European Commission on artificial intelligence. Health insurance funds and health mutuals s......
Gambling and Covid: AIM updates its memorandum
In order to fight the Covid19 pandemic and prevent its spread, governments are currently forced to take strict confinement measures. While those measures included the cancellation of all sports events......
The impact of solvency II rules on mutual benefit societies in the sector of social protection
AIM has drafted a paper providing the European institutions with information and knowledge on how Solvency II affects them. The paper allows for a reasoned reflection on possible future policy develop......